Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Salmon and Reduced Interleukin-6 Levels

Doses used in studies

mg/week: 3,000 (median 3,000, IQR 3,000–3,000) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

Short-Term Intake of Yellowstripe Scad versus Salmon Did Not Induce Similar Effects on Lipid Profile and Inflammatory Markers among Healthy Overweight Adults despite Their Comparable EPA+DHA Content.
- 2021-10-08
- RCT · n = 49
- Nutrients 13(10)
- - Wei Lin Chang
  - Azrina Azlan
  - Sabariah Md Noor
  - Irmi Zarina Ismail
  - Su Peng Loh
- PubMed: 34684525
- DOI: 10.3390/nu13103524
4 Insights on
- Reduced Interleukin-6 Levels
- High evidence
- Rigorous Journal
- Adults
consumption of salmon as compared with YSS was associated with reduction in ... IL-6 (between-group difference: -0.01 pg/mL, p = 0.03)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
≈246 g fillet/day, 3 days/week (≈1000 mg EPA+DHA/day)